% | $
Quotes you view appear here for quick access.

OncoSec Medical Incorporated Message Board

  • mofisher22 mofisher22 Feb 8, 2013 9:47 AM Flag

    When was last dilution? Is any in the next few months expected?


    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 12/13/12 they did a 7.2 million public offering

    • There won't be another dilution and partnering according to smithonstocks article (which I thinks is more accurate coverage article) sees it happening around end of 1H of this year. In an article published back on Nov. 8th, he said this:

      Sacha Pouget: Your priority is to sign a commercial partnership for the NeoPulse system. What do you aim to negotiate with your potential partner(s)?

      Punit Dhillon: We are in discussions with several partners, and we will negotiate the terms of both an “upfront” and milestones, as well as royalties. We also hope that the future partner will participate in future development costs.

      Sacha Pouget: What markets are you targeting first?

      Punit Dhillon: We wish to extend our products primarily in Europe and emerging countries (mainly in Asia). We have secured all our patents (recently we had a patent accepted in China). We own all intellectual property for NeoPulse, and we have the rights for ImmunoPulse from Inovio Pharmaceuticals, Inc. (NYSEAMEX:INO). We do not want to launch our own products on the market. We expect to sign partnerships.

      Sacha Pouget: Precisely, for discussions with potential partners: Can you tell us what kind of partnerships you will negotiate?

      Punit Dhillon: OncoSec has a unique “know-how”, and our technology has been demonstrated previously with significant advantages. We have some partners with whom we are currently negotiating. We cannot move forward on the details or the timing, but it could be announced at the end of the year or in 2013. We are negotiating with global and local potential partners.

      Our priority is to sign a global partnership, with a major player, but these discussions often take time and we cannot guarantee timing or outcome at this point in time. If these discussions with a global partner take too long, we will turn to a regional partner that will allow us to address our target markets first.

      In both cases (global or local), we will use the payments from the future partner to reallocate on our R&D expenses to develop our pipeline which is in the interest of our shareholders.

      Sentiment: Buy

    • The company has plenty of cash to last easily through 2013.

      Sentiment: Strong Buy

    • The CEO said in October interview that they have enough cash until the middle of this year.Also,they will announce their partner in the first quarter of this year.

      Sentiment: Strong Buy

1.82+0.03(+1.68%)Jul 29 4:00 PMEDT